Inside the Clinic: Treating AYA ALL - Episode 3

AYA ALL: Pediatric and Adult Inspired Regimens

, ,

Focusing on the current treatment landscape for patients with AYA ALL, the panel discusses clinical practices and treatment decisions based on age.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Clinical Scenario: A 23-Year-Old Male with AYA ALL
    EP. 2: AYA ALL: Overview and Risk Stratification
    Now Viewing
    EP. 3: AYA ALL: Pediatric and Adult Inspired Regimens
    EP. 4: AYA ALL: Role of Asparaginase Erwinia Chrysanthemi
    EP. 5: Asparaginase Erwinia Chrysanthemi: Side Effects and Hypersensitivity Reactions
    EP. 6: ALL AYA: Coordination of Care
    EP. 7: Clinical Scenario of a 32-Year-Old Female with AYA ALL and the Role of Cytogenetics in AYA ALL
    EP. 8: CALBG 10403 in AYA ALL
    EP. 9: The Potential of Modified Treatment Regimens in AYA ALL
    EP. 10: The Future of AYA ALL

    Video content above is prompted by the following questions:

    • What is the current treatment landscape for AYA ALL?
      • How has the treatment landscape evolved over time?
    • What is the role of asparaginase in the treatment of ALL in adolescents and young adults (AYA)?
      • What are some challenges in treating this patient population?
    • When treating AYA ALL in your practice, do you usually consider a pediatric-inspired regimen or an adult-inspired regimen?
      • Have you noticed a difference in outcomes between pediatric and adult regimens?
    x